USPTO serial 79278137
BRIGHTGENE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Aug 31, 2021
- Examiner
- RINKER, ANTHONY MICHAEL
- Law office
- TMO LAW OFFICE 119
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with BRIGHTGENE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $299*
Plus Government fees of $325
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
BrightGene Bio-Medical Technology Co., Ltd.
CN
Other trademarks owned by BrightGene Bio-Medical Technology Co., Ltd.
BrightGene Bio-Medical Technology Co., Ltd.
CN
Other trademarks owned by BrightGene Bio-Medical Technology Co., Ltd.
BrightGene Bio-Medical Technology Co., Ltd.
CN
Other trademarks owned by BrightGene Bio-Medical Technology Co., Ltd.
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Eric Lamb
Eric Lamb Frost Brown Todd LLC201 North Illinois Street, Suite 1900Frost Brown Todd LLC, IN 46204UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Injectable solutions for medical purposes for treatment of cardiovascular diseases, cerebrovascular diseases, viral infection, tumors, fungal infections, bacterial infection, iron-deficiency disease, and immune system disorders; prepared Chinese medicine for treatment of cardiovascular diseases, cerebrovascular diseases, viral infection, tumors, fungal infections, bacterial infection, iron-deficiency disease, and immune system disorders; chemical pharmaceutical preparations for treatment of cardiovascular diseases, cerebrovascular diseases, viral infection, tumors, fungal infections, bacterial infection, iron-deficiency disease, and immune system disorders; medicinal preparations for the mouth in the form of tablets or compressed tablets for treatment of cardiovascular diseases, cerebrovascular diseases, viral infection, tumors, fungal infections, bacterial infection, iron-deficiency disease, and immune system disorders; medicines for human purposes for treatment of cardiovascular diseases, cerebrovascular diseases, viral infection, tumors, fungal infections, bacterial infection, iron-deficiency disease, and immune system disorders; biochemical medical drug for treatment of cardiovascular diseases, cerebrovascular diseases, viral infection, tumors, fungal infections, bacterial infection, iron-deficiency disease, and immune system disorders; pharmaceutical preparations for treatment of cardiovascular diseases, cerebrovascular diseases, viral infection, tumors, fungal infections, bacterial infection, iron-deficiency disease, and immune system disorders; chemical preparations for medical purposes for treatment of cardiovascular diseases, cerebrovascular diseases, viral infection, tumors, fungal infections, bacterial infection, iron-deficiency disease, and immune system disorders; drugs for medical purposes for treatment of cardiovascular diseases, cerebrovascular diseases, viral infection, tumors, fungal infections, bacterial infection, iron-deficiency disease, and immune system disorders; active pharmaceutical ingredients for treatment of cardiovascular diseases, cerebrovascular diseases, viral infection, tumors, fungal infections, bacterial infection, iron-deficiency disease, and immune system disorders | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by BrightGene Bio-Medical Technology Co., Ltd.
- Other trademarks owned by BrightGene Bio-Medical Technology Co., Ltd.
- Other trademarks owned by BrightGene Bio-Medical Technology Co., Ltd.
- Other trademarks in Class 005
- Similar marks named BRIGHTGENE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 31, 2026 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Aug 31, 2026 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Feb 27, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Feb 7, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Feb 7, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Nov 30, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Aug 31, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 24, 2021 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jul 7, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jul 7, 2021 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Jun 15, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 15, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 13, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| May 26, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 26, 2021 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| May 26, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 10, 2021 | ALIE | ASSIGNED TO LIE | — |
| May 10, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 20, 2020 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Oct 20, 2020 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Oct 20, 2020 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Sep 18, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 17, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 17, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 17, 2020 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Sep 17, 2020 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 17, 2020 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 17, 2020 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Sep 17, 2020 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Apr 17, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 27, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 26, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 12, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 11, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 10, 2020 | RFWR | NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW | — |
| Feb 19, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Feb 18, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 14, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Feb 10, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 10, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 6, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |